Drugs and Devices

FDA authorizes use of Ebola test

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize use of the LightMix® Ebola Zaire rRT-PCR Test for the presumptive detection of the Ebola Zaire virus in a preparation of whole blood from individuals with signs and symptoms of Ebola disease. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares